Merck Announces Initiation of Pivotal Phase 2b/3 Trial Evaluating MK-8748 , an Investigational Bispecific Tie2 Agonist/VEGF Inhibitor, for the Treatment of Neovascular Age-Related Macular Degeneration
European Commission Approves KEYTRUDA® Plus Paclitaxel ± Bevacizumab for the Treatment of Adults With PD-L1 Platinum-Resistant Recurrent Ovarian Carcinoma Who Have Received One or Two Prior Systemic Treatment Regimens
Merck's Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions at Eight Weeks Compared to Guideline-Recommended Oral Non-Statin Therapies When Added to Background Statins
Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for WINREVAIR in Adults With the Syndrome of Combined Post- and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia
FDA Approves BRAVECTO® QUANTUM from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs
Merck to Present New Data Reinforcing Long-Term Efficacy of GARDASIL®9 and GARDASIL® at the EUROGIN International Multidisciplinary HPV Congress 2026
Merck Highlights New Data from Cardio-Pulmonary Pipeline at ACC.26 Showcasing Commitment to Advance Innovative Research
FDA Approves NUMELVI for Dogs from Merck Animal Health - The First and Only Second-Generation Janus Kinase Inhibitor for the Control of Pruritus Associated with Allergic Dermatitis
Merck Announces Late-Breaking Data from Three Phase 3 Trials Evaluating Doravirine/Islatravir , an Investigational, Once-Daily, Two-Drug Regimen for the Treatment of Adults Living with HIV-1 at CROI 2026
Merck Announces Positive New Data for ENFLONSIA for Infants and Children Under 2 Years of Age at Increased Risk for Severe Respiratory Syncytial Virus Disease Over Two RSV Seasons
Allied Critical Metals Intersects Over 200 Metres of Breccia-Hosted Tungsten Mineralization at New Venise Target, Expanding Growth Potential at the Borralha Project
Allied Critical Metals Intersects Over 200 Metres of Breccia-Hosted Tungsten Mineralization at New Venise Target, Expanding Growth Potential at the Borralha Project
Miivo Holdings: Delivering Real-time Financial and Operational Intelligence to Small and Midsized Enterprises
